DCF — UNIVERSITY HEALTH LAKEWOOD MED CTR
Enterprise Value: $-140.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-140.4M
Enterprise Value
$-47.0M
PV of Cash Flows
$-93.4M
PV of Terminal Value
$-150.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $163.5M | $-7.4M | -4.0% | $-14.3M | $-13.0M |
| Year 2 | $168.4M | $-5.9M | -3.0% | $-13.0M | $-10.8M |
| Year 3 | $173.5M | $-4.3M | -2.0% | $-11.7M | $-8.8M |
| Year 4 | $178.7M | $-3.6M | -2.0% | $-11.1M | $-7.6M |
| Year 5 | $184.0M | $-3.2M | -2.0% | $-11.0M | $-6.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-140.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$158.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999998425214756
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5